Real-World Use of Dalbavancin in the Era of Empowerment of Outpatient Antimicrobial Treatment: A Careful Appraisal Beyond Approved Indications Focusing on Unmet Clinical Needs-Reference-Cited by-同舟云学术

Real-World Use of Dalbavancin in the Era of Empowerment of Outpatient Antimicrobial Treatment: A Careful Appraisal Beyond Approved Indications Focusing on Unmet Clinical Needs

Published:2021-08 Issue: Volume:Volume 15 Page:3349-3378
ISSN:1177-8881
Container-title:Drug Design, Development and Therapy
language:en
Short-container-title:DDDT

Author:

Gatti Milo,Andreoni Massimo,Pea Federico^ORCID,Viale Pierluigi

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmaceutical Science,Pharmacology

Reference89 articles.

1. Andreoni M, Bassetti M, Corrao S, De Rosa FG, Esposito V, Falcone M, Grossi P, Pea F, Petrosillo N, Tascini C, Venditti M, Viale P. The role of dalbavancin for Gram positive infections in the COVID-19 era: state of the art and future perspectives. Expert Rev Anti Infect Ther. 2021 Mar 16:1–10. doi:10.1080/14787210.2021.1894130. Epub ahead of print.

2. Extended-Duration Dosing and Distribution of Dalbavancin into Bone and Articular Tissue

3. Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection

4. A Randomized Clinical Trial of Single-Dose Versus Weekly Dalbavancin for Treatment of Acute Bacterial Skin and Skin Structure Infection

5. Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical, organizational, and pharmacoeconomic perspectives of dalbavancin vs standard of care in the infectious disease network;Global and Regional Health Technology Assessment;2024-07-29

2. Enteroccocus and Endocarditis;Infectious Diseases;2024-06-11

3. Pharmacotherapies for multidrug-resistant gram-positive infections: current options and beyond;Expert Opinion on Pharmacotherapy;2024-05-23

4. Dalbavancin for Acute Bacterial Skin and Skin Structure Infections in Pediatrics: Insights from Continuation Therapy Experience;Antibiotics;2024-04-04

5. Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study;Infectious Diseases and Therapy;2024-03